小智港股覆盤 | 10月18日
今日,港股三大指數集體上漲。截止收盤,恆生指數漲1.82%,報16914點。國企指數大漲2.18%,報5756點。恆生科技指數大漲4.25%,報3336點。市場約1073只個股上漲,547只個股下跌。成交額突破997.56億港幣,和昨天同期相比增長4.17%。南下資金淨流入51.31億港幣。

盤面上,生物科技板塊全線走強。科濟藥業-B漲超21%;中國再生醫學、榮昌生物-B等多股漲超19%;信達生物漲超14%;諾誠健華-B漲超11%。科濟藥業-B升9%,核心產品澤沃基奧侖賽國內上市申請獲受理;榮昌生物早盤漲超12%,公司發佈股權激勵計劃,2027年營收目標50億元;信達生物漲8.75%,中信建投看好GLP-1賽道;諾誠健華-B升6% 奧布替尼治療復發/難治性WM II期研究結果發佈。

互聯網醫療板塊暴漲。阿裏健康漲超9%;平安好醫生漲超5%;醫渡科技漲超3%;醫脈通漲超2%;鷹瞳科技-B漲超1%。

信息技術板塊集體拉昇。移卡漲超8%;萬國數據-SW、中國軟件國際等多股漲超7%;自動系統漲超5%;新意網集團漲超4%。移卡午後漲5.54%,近日獲多方增持合計逾96萬股。

專業服務板塊走低。中國卓銀跌超12%;星亞控股跌超7%;烯石電車新材料跌超6%;今海國際跌超4%;羅馬元宇宙集團跌超2%。

菸草板塊走弱。思摩爾國際跌超1%。

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.